Biofourmis has restructured its business to pursue its original focus on data-driven patient monitoring alongside its more recent interest in standalone and companion digital therapeutics.
Topic:
SoftBank leads $100M investment for intelligent health monitoring and digital therapeutics startup Biofourmis
More Regional News
CISA offers guide to shore up operational technology against threats
